A woman sleeps comfortably on a bed surrounded by pillows and blankets, capturing a serene and restful moment.
cottonbro studio (Pexels) / Pexels License
Lifestyle/June 26, 2026/3 min read

Low Blood Sugar Still Affects Quality of Life—Even With Advanced Technology

A new survey of U.S. adults using continuous glucose monitors and insulin pumps reveals that hypoglycemia continues to disrupt sleep, work, and daily activities for the vast majority, regardless of their technology.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

lifestyleexercisesleepstress

Key takeaways

  • 96% of adults using CGM or hybrid closed-loop insulin pumps reported that low blood sugar negatively affected at least one area of their life
  • Sleep, leisure activities, emotional well-being, and spontaneity were the most commonly disrupted life areas
  • Surprisingly, hybrid closed-loop pump users reported greater negative impacts from lows in some categories than CGM-only users
  • Nearly one-third of participants experienced negative impacts across 10 or more different life domains

The Persistent Impact of Low Blood Sugar

Even as continuous glucose monitoring (CGM) systems and hybrid closed-loop insulin pumps have become more widely available, a new U.S. national survey shows that low blood sugar—hypoglycemia—continues to significantly disrupt the daily lives of adults with Type 1 diabetes.

The research involved 796 U.S. adults aged 18 and older, most of whom (77%) were using hybrid closed-loop insulin pumps, while 23% used CGM alone. Researchers asked participants about how low blood sugar affected their quality of life across 12 different life domains, from sleep and work to relationships and emotional well-being.

Where Low Blood Sugar Takes Its Toll

Nearly all participants—96%—reported that hypoglycemia negatively affected at least one area of their life. Even more striking, about one-third reported negative impacts in 10 or more of the 12 domains assessed.

Sleep emerged as the most commonly disrupted area, followed by leisure activities, emotional well-being, and spontaneity. Physical activity and fitness also featured prominently among the affected domains, suggesting that fear or experience of lows can limit exercise and outdoor activities.

An Unexpected Finding: Why Some Pump Users Report More Impact

The study revealed a surprising finding: adults using hybrid closed-loop insulin pumps reported greater negative impacts from low blood sugar in some life areas compared to those using CGM alone. Specifically, pump users reported more disruption to leisure activities, physical activity and fitness, spontaneity, sex life, and work.

This counterintuitive result suggests that the relationship between technology and quality of life is more complex than simply 'newer technology equals fewer problems.' It may reflect that hybrid closed-loop users have different expectations, use patterns, or experiences with hypoglycemia than CGM-only users—a finding that points to the need for further research into how people live with these devices day-to-day.

What This Means for People Living With Type 1

This research underscores that while contemporary diabetes technologies are valuable tools, hypoglycemia remains a significant challenge in the lives of adults with Type 1 diabetes. The survey highlights that managing low blood sugar affects far more than physical health—it influences emotional well-being, relationships, work performance, and the ability to engage in activities people enjoy.

The findings suggest that a complete approach to Type 1 diabetes care should address not only the technological management of blood glucose, but also the broader quality-of-life impacts of hypoglycemia. This may include conversations with healthcare providers about individual experiences, strategies for managing the fear and disruption caused by lows, and support for mental and emotional well-being alongside blood sugar management.

Evidence label

Source: Diabetes, obesity & metabolism. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.